Literature DB >> 2216606

IgG subclass concentrations in absolute, partial and transient IgA deficiency in childhood.

D M Roberton1, T Colgan, A Ferrante, C Jones, N Mermelstein, F Sennhauser.   

Abstract

Sixty-seven children with symptomatic IgA deficiency were studied on two separate occasions. Eighteen had aIgAd at presentation, and 49 had pIgAd. IgA concentrations had risen to the normal range for age in 22.2% of children presenting with aIgAd and 77.6% presenting with pIgAd when restudied at a median interval of 3.2 and 3.0 years, respectively. IgG subclass concentrations were measured by enzyme immunoassay in serum samples collected at enrollment from 12 children with aIgAd and 22 children with pIgAd. IgG2 and IgG4 concentrations for these 34 children were below the 5th centile for age and sex more frequently than expected (IgG2: chi square 5.8, P less than 0.025; IgG 4: chi square 18.4, P less than 0.0005). The prevalence of IgG2 deficiency or IgG4 deficiency did not differ significantly between those with aIgAd and those with pIgAd. IgG2 concentrations remained below the 5th centile more frequently than expected when retested in 31 children whose pIgAd had resolved (chi square 4.6, P less than 0.05). Children with aIgAd at presentation had IgG1 and IgG2 concentrations above the 95th centile more frequently than expected (IgG1: chi square 19.7, P less than 0.0005; IgG2: chi square 13.5, P less than 0.001) but this was not seen for IgG3 and IgG4 concentrations. Children with pIgAd did not have elevated IgG1 or IgG2 concentrations at presentation. High IgG1 and IgG2 concentrations in aIgAd may be a compensatory mechanism to afford protection from infection or could be part of a selective secondary response to repeated episodes of infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216606

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

Review 1.  Future prospects for the drug treatment of epilepsy.

Authors:  A Nicolson; J P Leach
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Clinical and Laboratory Features of 184 Italian Pediatric Patients Affected with Selective IgA Deficiency (SIgAD): a Longitudinal Single-Center Study.

Authors:  Vassilios Lougaris; Annamaria Sorlini; Chiara Monfredini; Giulia Ingrasciotta; Andrea Caravaggio; Tiziana Lorenzini; Manuela Baronio; Marco Cattalini; Antonella Meini; Laura Ruggeri; Annamaria Salpietro; Alba Pilotta; Livia Grazzani; Elena Prandi; Barbara Felappi; Giulio Gualdi; Antonella Fabiano; Maurizio Fuoti; Alberto Ravelli; Vincenzo Villanacci; Annarosa Soresina; Raffaele Badolato; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2019-05-25       Impact factor: 8.317

3.  Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.

Authors:  E R Staples; E M McDermott; A Reiman; P J Byrd; S Ritchie; A M R Taylor; E G Davies
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

Review 4.  The Clinical Utility of Measuring IgG Subclass Immunoglobulins During Immunological Investigation for Suspected Primary Antibody Deficiencies.

Authors:  Antony R Parker; Markus Skold; David B Ramsden; J Gonzalo Ocejo-Vinyals; Marcos López-Hoyos; Stephen Harding
Journal:  Lab Med       Date:  2017-11-08

5.  Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections.

Authors:  Ana M Koatz; Noemí A Coe; Alberto Cicerán; Adriana J Alter
Journal:  Lung       Date:  2016-04-27       Impact factor: 2.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.